scholarly journals Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer

2013 ◽  
Vol 14 (1) ◽  
pp. 13-19 ◽  
Author(s):  
Yoshimichi Tanaka ◽  
Yoshito Terai ◽  
Hiroshi Kawaguchi ◽  
Satoe Fujiwara ◽  
Saha Yoo ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Protein Expression ◽  
Epithelial Mesenchymal Transition ◽  
Prognostic Impact ◽  
Related Protein ◽  
Mesenchymal Transition

Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma

2009 ◽  
Vol 54 (4) ◽  
pp. 442-451 ◽  
Author(s):  
Min A Kim ◽  
Hye Seung Lee ◽  
Hee Eun Lee ◽  
Ji Hun Kim ◽  
Han-Kwang Yang ◽  
...  
Keyword(s):  
Gastric Carcinoma ◽  
Protein Expression ◽  
Epithelial Mesenchymal Transition ◽  
Related Protein ◽  
Mesenchymal Transition ◽  
Prognostic Importance

scholarly journals Antitumor Effect of Saikosaponin A on Human Neuroblastoma Cells

2021 ◽  
Vol 2021 ◽  
pp. 1-12
Author(s):  
Tan Cheng ◽  
Muying Ying
Keyword(s):  
Protein Expression ◽  
Epithelial Mesenchymal Transition ◽  
Neuroblastoma Cells ◽  
Metastatic Tumor ◽  
Inhibitory Effect ◽  
Migration And Invasion ◽  
Related Protein ◽  
Human Neuroblastoma ◽  
Mesenchymal Transition ◽  
Saikosaponin A

Objective. Neuroblastoma (NB) is a highly metastatic tumor in children that develops in the sympathetic nervous system and has a low curative rate. Saikosaponin A (SSA), an active ingredient isolated from the root of Radix Bupleuri, is a natural compound with various pharmacological activities and shows good application prospects in antitumors. This study investigated the antihuman NB activity of SSA and underlying mechanisms associated with its actions. Materials and Methods. The MTT method was used to detect the activity of SSA in inhibiting human NB cell SK-N-AS proliferation. Cell morphology was observed. The flow cytometry technology was used in analyzing the cell apoptosis rate. The Transwell assay evaluated cell migration and invasion following SSA treatment, apoptosis-related protein expression, and angiogenesis-related protein expression, and EMT-related proteins were detected by western blot analysis. Results. SSA showed an inhibitory effect on SK-N-AS cells with the IC50 values of 14.14 μM at 24 h and 12.41 μM at 48 h. Results indicated that SSA has proapoptotic activity, and its proapoptotic activity is positively correlated with the Bax/Bcl-2/caspase-9/caspase-7/PARP pathway. Furthermore, SSA inhibited the invasion and migration of SK-N-AS cells via regulating the angiogenesis-related VEGFR2/Src/Akt pathway and the epithelial-mesenchymal transition- (EMT-) related protein expression. Conclusion. SSA exerts an antihuman NB effect and thus provides foundations for NB treatment.

scholarly journals miR-33a Mediates the Anti-Tumor Effect of Lovastatin in Osteosarcoma by Targeting CYR61

2018 ◽  
Vol 51 (2) ◽  
pp. 938-948 ◽  
Author(s):  
Yazeng Huang ◽  
Jun Zhang ◽  
Haiyu Shao ◽  
Jianwen Liu ◽  
Mengran Jin ◽  
...  
Keyword(s):  
Protein Expression ◽  
Cell Invasion ◽  
Epithelial To Mesenchymal Transition ◽  
Regulatory Element ◽  
Luciferase Reporter Assay ◽  
Luciferase Reporter ◽  
Osteosarcoma Cell ◽  
Reporter Assay ◽  
Related Protein ◽  
Mesenchymal Transition

Background/Aims: Preventing cell metastasis is an effective therapeutic strategy to treat osteosarcoma and improve prognosis. Statins have been found to have anticancer effects in addition to their cholesterol-lowering action. As a new target of statins, cysteine-rich 61 (CYR61) was recently identified to promote cell migration and metastasis in osteosarcoma. However, the underlying mechanisms mediating the regulation of CYR61 expression by statins remain unknown. Methods: Human osteosarcoma cell lines MG63 and SaOS2 were used to clarify the effect of lovastatin on CYR61 expression. Real-time PCR was performed to detect mRNA or microRNA (miRNA) levels and western blot was performed to detect protein levels. Cell invasive ability was determined using Transwell assays. Lentivirus encoding CYR61 cDNA or sterol regulatory element-binding protein 2 (SREBP-2) shRNA was used to upregulate CYR61 expression or downregulate SREBP-2 expression. Binding of the CYR61 3’ untranslated region (UTR) and miR-33a was analyzed by luciferase reporter assay. Results: We found that lovastatin treatment decreased CYR61 expression, inhibited cell invasion and altered epithelial-to-mesenchymal-transition (EMT)-related protein expression, while CYR61 overexpression abolished the effect of lovastatin. Moreover, lovastatin increased the expression of SREBP-2 and miR-33a, which were then downregulated by SREBP-2 silencing. Bioinformatics analysis indicated that the CYR61 3′UTR harbored a potential miR-33a binding site and luciferase reporter assay demonstrated that CYR61 was a target of miR-33a in osteosarcoma cells. Furthermore, miR-33a could inhibit cell invasion and alter EMT-related protein expression. SREBP-2 silencing or miR-33a inhibitor upregulated CYR61 expression and reversed the effects of lovastatin on cell invasion and EMT-related proteins. Conclusion: Our findings suggest lovastatin suppresses osteosarcoma cell invasion through the SREBP-2/miR-33a/CYR61 pathway.

Sign in / Sign up

Export Citation Format

Share Document